Marwa Meheissen1, Doaa Header2, Khaled Abdelaty2. 1. MD, Medical Microbiology & Immunology Department, Faculty of Medicine, Alexandria University, 21521, Egypt. 2. MD, Internal Medicine Department, Faculty of Medicine, Alexandria University, 21521, Egypt.
Abstract
INTRODUCTION: The role of Escherichia coli in the pathogenesis of inflammatory bowel disease (IBD) is still controversial. The study aimed to investigate the pathotypes and the phylogenetic groups of E. coli in Egyptian patients with IBD in an attempt to find an association between any type or group with the severity of the disease. METHODS: Thirty ulcerative colitis (UC), 30 Crohn's disease (CD), and 20 control subjects with normal colonoscopy were included in a cross-sectional study. E. coli were isolated from stool samples by culture. Eight intestinal virulence genes coding for diarrheagenic E. coli were investigated using multiplex PCR. Phylogenetic grouping was performed by a triplex PCR. Antimicrobial susceptibility of all isolates was done using disc diffusion method. RESULTS: Enteroaggregative E. coli (EAEC) were identified in 25% (15/60) of IBD cases and in none of the controls (p=0.013). Out the 60 IBD cases, 30 (50%) were from phylogenetic group B2. No statistically significant differences in the distribution of E. coli phylogenetic groups were found between study groups. However, 80% of EAEC were assigned to group B2 and D. No statistically significant differences in calprotectin level or in disease severity scores were reported between the four phylogenetic groups. E. coli from both UC and CD patients showed a high rate of resistance to most antimicrobials when compared to the control group. CONCLUSIONS: The identification of EAEC belonging mainly to group B2 and D in IBD cases may indicate the importance of this pathotype in the pathogenesis of IBD in Egyptian patients. GERMS.
INTRODUCTION: The role of Escherichia coli in the pathogenesis of inflammatory bowel disease (IBD) is still controversial. The study aimed to investigate the pathotypes and the phylogenetic groups of E. coli in Egyptian patients with IBD in an attempt to find an association between any type or group with the severity of the disease. METHODS: Thirty ulcerative colitis (UC), 30 Crohn's disease (CD), and 20 control subjects with normal colonoscopy were included in a cross-sectional study. E. coli were isolated from stool samples by culture. Eight intestinal virulence genes coding for diarrheagenic E. coli were investigated using multiplex PCR. Phylogenetic grouping was performed by a triplex PCR. Antimicrobial susceptibility of all isolates was done using disc diffusion method. RESULTS: Enteroaggregative E. coli (EAEC) were identified in 25% (15/60) of IBD cases and in none of the controls (p=0.013). Out the 60 IBD cases, 30 (50%) were from phylogenetic group B2. No statistically significant differences in the distribution of E. coli phylogenetic groups were found between study groups. However, 80% of EAEC were assigned to group B2 and D. No statistically significant differences in calprotectin level or in disease severity scores were reported between the four phylogenetic groups. E. coli from both UC and CD patients showed a high rate of resistance to most antimicrobials when compared to the control group. CONCLUSIONS: The identification of EAEC belonging mainly to group B2 and D in IBD cases may indicate the importance of this pathotype in the pathogenesis of IBD in Egyptian patients. GERMS.
Entities:
Keywords:
E. coli; IBD; enteroaggregative; phylogenetic group
Authors: Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso Journal: Int J Med Microbiol Date: 2014-02-06 Impact factor: 3.473
Authors: Stina Rikke Jensen; Hengameh Chloé Mirsepasi-Lauridsen; Anna Hammerich Thysen; Jørn Brynskov; Karen A Krogfelt; Andreas Munk Petersen; Anders Elm Pedersen; Susanne Brix Journal: Int J Med Microbiol Date: 2015-10-22 Impact factor: 3.473
Authors: Helton Luis de Souza; Vanessa R de Carvalho; Fernando Gomes Romeiro; Ligia Yukie Sassaki; Rogeria Keller; Josias Rodrigues Journal: Gut Pathog Date: 2012-12-13 Impact factor: 4.181
Authors: Thanaa El A Helal; Hoda E El Abdel Wahab; Sally M Saber; Waleed H Abdelaaty; Mohamed M Eltabbakh; Ahmed M Aref; Mohamed H Dawood Journal: Afr Health Sci Date: 2022-03 Impact factor: 1.108